Effect of phenobarbital on hepatic cell proliferation and apoptosis in mice deficient in the p50 subunit of NF-κB

Toxicology and Applied Pharmacology

Volumn 226, Issue 3, 2008, Pages 338-344

  Tharappel, Job C ^a   Spear, Brett T ^a,b   Glauert, Howard P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Apoptosis; Cell proliferation; NF B; Phenobarbital

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR; PHENOBARBITAL; PROTEIN P50; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA BINDING; DRUG EFFECT; FEMALE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; LIVER CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROMOTER REGION;

ADMINISTRATION, ORAL; ANIMALS; APOPTOSIS; CARCINOGENS; CELL PROLIFERATION; DIET; FEMALE; GENE EXPRESSION; GENE SILENCING; HEPATOCYTES; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; PHENOBARBITAL; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 38649141875     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2007.09.019     Document Type: Article

References (41)

1. Barbason H., Rassenfosse C., and Betz E.H. Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect. Br. J. Cancer 47 (1983) 517-525
2. Barkett M., and Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6910-6924
3. Brawn M.K., Chiou W.J., and Leach K.L. Oxidant-induced activation of protein kinase C in UC11MG cells. Free Radic. Res. 22 (1995) 23-37
4. Butler W.H., and Hempsall V. Histochemical observations on nodules induced in the mouse liver by phenobarbitone. J. Pathol. 125 (1978) 155-161
5. Butterworth B.E., Conolly R.B., and Morgan K.T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 93 (1995) 129-146
6. Calfee-Mason K.G., Spear B.T., and Glauert H.P. Vitamin E inhibits hepatic NF-kappa B activation in rats administered the hepatic tumor promoter, phenobarbital. J. Nutr. 132 (2002) 3178-3185
7. DeAngelis R.A., Kovalovich K., Cressman D.E., and Taub R. Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. Hepatology 33 (2001) 915-924
8. Deryckere F., and Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques 16 (1994) 405
9. Farber E. Possible etiologic mechanisms in chemical carcinogenesis. Environ. Health. Perspect. 75 (1987) 64-70
10. Feig D.I., Reid T.M., and Loeb L.A. Reactive oxygen species in tumorigenesis. Cancer Res. 54 (1994) 1890s-1894s
11. Feldman D., Swarm R.L., and Becker J. Ultrastructural study of rat liver and liver neoplasms after long-term treatment with phenobarbital. Cancer Res. 41 (1981) 2151-2162
12. Frueh F.W., Zanger U.M., and Meyer U.A. Extent and character of phenobarbital-mediated changes in gene expression in the liver. Mol. Pharmacol. 51 (1997) 363-369
13. Glauert H.P., Eyigor A., Tharappel J.C., Cooper S., Lee E.Y., and Spear B.T. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kB in mice administered the peroxisome proliferator Wy-14,643. Toxicol. Sci. 90 (2006) 331-336
14. Hinz M., Krappmann D., Eichten A., Heder A., Scheidereit C., and Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol. Cell. Biol. 19 (1999) 2690-2698
15. Honkakoski P., and Negishi M. Regulatory DNA elements of phenobarbital-responsive cytochrome P450 CYP2B genes. J. Biochem. Mol. Toxicol. 12 (1998) 3-9
16. Jirtle R.L., and Meyer S.A. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and transformation growth factor-á1 expression. Dig. Dis. Sci. 36 (1991) 659-668
17. Jirtle R.L., Carr B.I., and Scott C.D. Modulation of isuline-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-b1 during liver regeneration. J. Biol. Chem. 266 (1991) 22444-22450
18. Kaufmann W.K., Byrd L.L., Palmieri D., Nims R.W., and Rice J.M. TGF-alpha sustains clonal expansion by promoter-dependent, chemically initiated rat hepatocytes. Carcinogenesis 18 (1997) 1381-1387
19. Klaunig J.E., Xu Y., Isenberg J.S., Bachowski S., Kolaja K.L., Jiang J., Stevenson D.E., and Walborg Jr. E.F. The role of oxidative stress in chemical carcinogenesis. Environ. Health. Perspect. 106 Suppl 1 (1998) 289-295
20. Li N., and Karin M. Is NF-kappaB the sensor of oxidative stress?. FASEB J. 13 (1999) 1137-1143
21. Li Y., Leung L.K., Spear B.T., and Glauert H.P. Activation of hepatic NF-kappaB by phenobarbital in rats. Biochem. Biophys. Res. Commun. 229 (1996) 982-989
22. Lu Z., Lee E.Y., Robertson L.W., Glauert H.P., and Spear B.T. Effect of 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB-153) on hepatocyte proliferation and apoptosis in mice deficient in the p50 subunit of the transcription factor NF-kB. Toxicol. Sci. 81 (2004) 35-42
23. Manjeshwar S., Rao P.M., Rajalakshmi S., and Sarma D.S.R. Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal rat liver and from hepatic nodules. Carcinogenesis 13 (1992) 2287-2291
24. Peraino C., Fry R.J.M., and Staffeldt E.F. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31 (1971) 1506-1512
25. Pitot H.C., Goldsworthy T.L., Moran S., Kennan W., Glauert H.P., Maronpot R.R., and Campbell H.A. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8 (1987) 1491-1499
26. Plaksin D., Baeuerle P.A., and Eisenbach L. KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells. J. Exp. Med. 177 (1993) 1651-1662
27. Sandgren E.P., Schroeder J.A., Qui T.H., Palmiter R.D., Brinster R.L., and Lee D.C. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res. 55 (1995) 3915-3927
28. Santoni-Rugiu E., Jensen M.R., and Thorgeirsson S.S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res. 58 (1998) 123-134
29. Schulte-Hermann R., Timmermann-Trosiener I., Barthel G., and Bursch W. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50 (1990) 5127-5135
30. Schwabe R.F., and Brenner D.A. Mechanisms of liver injury: I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol.: Gasterointest. Liver Physiol. 290 (2006) G583-G589
31. Sha W.C., Liou H.C., Tuomanen E.I., and Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80 (1995) 321-330
32. Smith G.H., Sharp R., Kordon E.C., Jhappan C., and Merlino G. Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am. J. Pathol. 147 (1995) 1081-1096
33. Storz G., and Polla B.S. Transcriptional regulators of oxidative stress-inducible genes in prokaryotes and eukaryotes. Exs 77 (1996) 239-254
34. Sueyoshi T., and Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 123-143
35. Tharappel J.C., Cunningham M.L., Spear B.T., and Glauert H.P. Differential activation of hepatic NF-kappaB in rats and hamsters by the peroxisome proliferators Wy-14,643, gemfibrozil, and dibutyl phthalate. Toxicol. Sci. 62 (2001) 20-27
36. Tharappel J.C., Nalca A., Owens A.B., Ghabrial L., Konz E.C., Glauert H.P., and Spear B.T. Cell proliferation and apoptosis are altered in mice deficient in the NF-kappaB p50 subunit after treatment with the peroxisome proliferator ciprofibrate. Toxicol. Sci. 75 (2003) 300-308
37. Tharappel J.C., Spear B.T., Lehmler H.J., Lee E.Y., Robertson L.W., and Glauert H.P. Effect of the deletion of the p50 subunit of NF-kB on hepatocarcinogenesis in mice receiving diethylnitrosamine and polychlorinated biphenyls. Toxicol. Sci. (Toxicologist supplement) 90 (2006) 249
38. Ueda A., Hamadeh H.K., Webb H.K., Yamamoto Y., Sueyoshi T., Afshari C.A., Lehmann J.M., and Negishi M. Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol. Pharmacol. 61 (2002) 1-6
39. Waxman D.J., and Azaroff L. Phenobarbital induction of cytochrome P-450 gene expression. Biochem. J. 281 Pt 3 (1992) 577-592
40. Zhong H., May M.J., Jimi E., and Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9 (2002) 625-636
41. Zhong H., Voll R.E., and Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1 (1998) 661-671